表紙:mヘルス市場:タイプ別、用途別、利害関係者別:世界の機会分析と産業予測、2023年~2032年
市場調査レポート
商品コード
1365571

mヘルス市場:タイプ別、用途別、利害関係者別:世界の機会分析と産業予測、2023年~2032年

mHealth Market By Type, By Application, By Stakeholders : Global Opportunity Analysis and Industry Forecast, 2023-2032


出版日
ページ情報
英文 350 Pages
納期
2~3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
mヘルス市場:タイプ別、用途別、利害関係者別:世界の機会分析と産業予測、2023年~2032年
出版日: 2023年07月01日
発行: Allied Market Research
ページ情報: 英文 350 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Allied Market Research社が発行した新しいレポート「mヘルス市場」によると、mヘルス市場は2022年に707億米ドルと評価され、2023年から2032年までのCAGRは18%で成長し、2032年には3,707億米ドルに達すると推定されています。

モバイルヘルス(mヘルス)は、医療や公衆衛生の実践をサポートするために、医療におけるスマートフォンやタブレットなどのモバイル機器の使用と定義されます。mヘルスは主に、糖尿病、高血圧、心臓病など、いくつかの急性および慢性疾患のモニタリングや治療に展開されるワイヤレス技術の使用を含みます。

mHealth Market-IMG1

世界のmヘルス市場の成長を促進する主な要因には、医療機器の急速な技術進歩、慢性心疾患を患う患者の増加、心臓病患者を監視するためのmヘルス機器の需要をさらに増加させる、糖尿病の有病率の上昇などがあります。例えば、米国疾病予防管理センター(CDC)の2022年によると、米国では2020年に約69万7,000人が心臓病で死亡しています。また、全米保健統計センター(National Center for Health Statistics 2022)によると、20秒に1人の割合でアメリカ人が心臓発作を起こしています。したがって、毎年100万人以上のアメリカ人が心臓発作を起こしていることになります。

しかし、規制遵守の確保に関する懸念がmヘルス市場の成長を制限すると予想されます。それとは反対に、新興諸国における医療支出の急増と、より良い治療の選択肢を得るための満たされていない医療需要は、将来的に世界市場拡大のための有利な機会を生み出すと予想されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • 心疾患の有病率の上昇
      • 糖尿病罹患率の増加
      • mヘルスとウェアラブルデバイスの需要増加
    • 抑制要因
      • 規制遵守の確保に関する懸念
    • 機会
      • 新興諸国における高い成長の可能性
      • 老人人口の増加
  • COVID-19市場への影響分析

第4章 mヘルス市場:タイプ別

  • 概要
  • mヘルス・デバイス
    • mヘルス機器デバイスタイプ別mヘルス市場
  • mヘルスサービス
    • mヘルスサービスサービスタイプ別mヘルス市場

第5章 mヘルス市場:用途別

  • 概要
  • 心血管
  • 糖尿病
  • 呼吸器
  • 神経
  • その他

第6章 mヘルス市場:利害関係者別

  • 事業概要
  • モバイル事業者
  • 端末ベンダー
  • 医療プロバイダー
  • アプリケーション・コンテンツ事業者

第7章 mヘルス市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • オーストラリア
    • インド
    • 韓国
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • その他

第8章 競争情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2022年

第9章 企業プロファイル

  • Boston Scientific Corporation
  • DexCom, Inc.
  • Fitbit
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Omada Health
  • Omron Corporation.
  • 南米SUNG ELECTRONICS CO., LTD.
  • Welldoc, Inc
  • Teladoc Health, Inc.
図表

LIST OF TABLES

  • TABLE 01. GLOBAL MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. MHEALTH MARKET FOR MHEALTH DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. GLOBAL MHEALTH DEVICES MHEALTH MARKET, BY DEVICE TYPE, 2022-2032 ($MILLION)
  • TABLE 04. MHEALTH MARKET FOR MHEALTH SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL MHEALTH SERVICES MHEALTH MARKET, BY SERVICE TYPE, 2022-2032 ($MILLION)
  • TABLE 06. GLOBAL MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 07. MHEALTH MARKET FOR CARDIOVASCULAR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. MHEALTH MARKET FOR DIABETES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. MHEALTH MARKET FOR RESPIRATORY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. MHEALTH MARKET FOR NEUROLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. MHEALTH MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 13. MHEALTH MARKET FOR MOBILE OPERATOR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. MHEALTH MARKET FOR DEVICE VENDORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. MHEALTH MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. MHEALTH MARKET FOR APPLICATION AND CONTENT PLAYERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. MHEALTH MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA MHEALTH MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 22. U.S. MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 23. U.S. MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. U.S. MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 25. CANADA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. CANADA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. CANADA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE MHEALTH MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. GERMANY MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 41. UK MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. UK MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. UK MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 44. ITALY MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. ITALY MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. ITALY MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 48. SPAIN MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. SPAIN MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. REST OF EUROPE MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC MHEALTH MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. JAPAN MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 60. CHINA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 61. CHINA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. CHINA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 63. AUSTRALIA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 64. AUSTRALIA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 66. INDIA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 67. INDIA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. INDIA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. SOUTH KOREA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. REST OF ASIA-PACIFIC MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 75. LAMEA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 76. LAMEA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. LAMEA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 78. LAMEA MHEALTH MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 79. BRAZIL MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 80. BRAZIL MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. BRAZIL MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 84. SAUDI ARABIA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH AFRICA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 90. REST OF LAMEA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 91. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 92. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 93. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
  • TABLE 94. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 95. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 96. DEXCOM, INC.: KEY EXECUTIVES
  • TABLE 97. DEXCOM, INC.: COMPANY SNAPSHOT
  • TABLE 98. DEXCOM, INC.: PRODUCT SEGMENTS
  • TABLE 99. DEXCOM, INC.: PRODUCT PORTFOLIO
  • TABLE 100. DEXCOM, INC.: KEY STRATERGIES
  • TABLE 101. FITBIT: KEY EXECUTIVES
  • TABLE 102. FITBIT: COMPANY SNAPSHOT
  • TABLE 103. FITBIT: PRODUCT SEGMENTS
  • TABLE 104. FITBIT: PRODUCT PORTFOLIO
  • TABLE 105. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 106. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 107. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS
  • TABLE 108. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 109. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
  • TABLE 110. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 111. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 112. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 113. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 114. MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 115. OMADA HEALTH: KEY EXECUTIVES
  • TABLE 116. OMADA HEALTH: COMPANY SNAPSHOT
  • TABLE 117. OMADA HEALTH: PRODUCT SEGMENTS
  • TABLE 118. OMADA HEALTH: PRODUCT PORTFOLIO
  • TABLE 119. OMADA HEALTH: KEY STRATERGIES
  • TABLE 120. OMRON CORPORATION.: KEY EXECUTIVES
  • TABLE 121. OMRON CORPORATION.: COMPANY SNAPSHOT
  • TABLE 122. OMRON CORPORATION.: SERVICE SEGMENTS
  • TABLE 123. OMRON CORPORATION.: PRODUCT PORTFOLIO
  • TABLE 124. OMRON CORPORATION.: KEY STRATERGIES
  • TABLE 125. SAMSUNG ELECTRONICS CO., LTD.: KEY EXECUTIVES
  • TABLE 126. SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT
  • TABLE 127. SAMSUNG ELECTRONICS CO., LTD.: PRODUCT SEGMENTS
  • TABLE 128. SAMSUNG ELECTRONICS CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 129. WELLDOC, INC: KEY EXECUTIVES
  • TABLE 130. WELLDOC, INC: COMPANY SNAPSHOT
  • TABLE 131. WELLDOC, INC: PRODUCT SEGMENTS
  • TABLE 132. WELLDOC, INC: PRODUCT PORTFOLIO
  • TABLE 133. WELLDOC, INC: KEY STRATERGIES
  • TABLE 134. TELADOC HEALTH, INC.: KEY EXECUTIVES
  • TABLE 135. TELADOC HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 136. TELADOC HEALTH, INC.: PRODUCT SEGMENTS
  • TABLE 137. TELADOC HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 138. TELADOC HEALTH, INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. MHEALTH MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF MHEALTH MARKET, 2022-2032
  • FIGURE 03. MHEALTH MARKET,2022-2032
  • FIGURE 04. TOP INVESTMENT POCKETS IN MHEALTH MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL MHEALTH MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. MHEALTH MARKET, BY TYPE, 2022(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR MHEALTH DEVICES, BY COUNTRY 2022-2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR MHEALTH SERVICES, BY COUNTRY 2022-2032(%)
  • FIGURE 14. MHEALTH MARKET, BY APPLICATION, 2022(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR CARDIOVASCULAR, BY COUNTRY 2022-2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR DIABETES, BY COUNTRY 2022-2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR RESPIRATORY, BY COUNTRY 2022-2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR NEUROLOGY, BY COUNTRY 2022-2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)
  • FIGURE 20. MHEALTH MARKET, BY STAKEHOLDERS, 2022(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR MOBILE OPERATOR, BY COUNTRY 2022-2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR DEVICE VENDORS, BY COUNTRY 2022-2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY 2022-2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR APPLICATION AND CONTENT PLAYERS, BY COUNTRY 2022-2032(%)
  • FIGURE 25. MHEALTH MARKET BY REGION, 2022
  • FIGURE 26. U.S. MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. CANADA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. MEXICO MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. GERMANY MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. FRANCE MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. UK MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. ITALY MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. SPAIN MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. REST OF EUROPE MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. JAPAN MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. CHINA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. AUSTRALIA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. INDIA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH KOREA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. BRAZIL MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. SAUDI ARABIA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SOUTH AFRICA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. REST OF LAMEA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49. COMPETITIVE DASHBOARD
  • FIGURE 50. COMPETITIVE HEATMAP: MHEALTH MARKET
  • FIGURE 51. TOP PLAYER POSITIONING, 2022
  • FIGURE 52. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 54. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. DEXCOM, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 56. DEXCOM, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 57. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 63. OMRON CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 64. OMRON CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 65. OMRON CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 66. SAMSUNG ELECTRONICS CO. LTD.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 67. SAMSUNG ELECTRONICS CO. LTD.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 68. SAMSUNG ELECTRONICS CO. LTD.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 69. TELADOC HEALTH, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 70. TELADOC HEALTH, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. TELADOC HEALTH, INC.: REVENUE SHARE BY REGION, 2022 (%)
目次
Product Code: A00015

According to a new report published by Allied Market Research, titled, "mHealth Market," The mhealth market was valued at $70.7 billion in 2022, and is estimated to reach $370.7 billion by 2032, growing at a CAGR of 18% from 2023 to 2032. Mobile health (mHealth) is defined as the use of mobile devices, such as smartphones and tablets, in healthcare to support medical and public health practice. mHealth majorly involves the use of wireless technologies, which are deployed in monitoring and treatment of several acute and chronic disorders such as diabetes, hypertension, heart diseases, and others.

mHealth Market - IMG1

Major factors that drive the growth of the global mHealth market include rapid technological advancements in medical devices, increase in the number of patients suffering from chronic heart diseases, which further increase the demand for mHealth devices for monitoring heart disease patients, and rise in prevalence of diabetes. For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, about 697,000 people in the U.S died from heart disease in 2020. In addition, according to a National Center for Health Statistics 2022, in every 20 seconds one American suffers a heart attack. Thus, more than 1 million Americans have a heart attack each year.

However, concerns related to ensuring regulatory compliance are expected to restrict the growth of the mHealth market. On the contrary, surge in healthcare expenditure and unmet medical demands to get better treatment options in developing countries are expected to create lucrative opportunities for the expansion of the global market in the future.

The mHealth market is segmented on the basis of type, application, stakeholder, and region. On the basis of type, the market is classified into mHealth devices and mHealth services. The mHealth devices segment is further categorized into blood glucose meter, blood pressure monitors, pulse oximetry, neurological monitors, cardiac monitors, apnea & sleep monitors, wearable fitness sensor device & heart rate meters, and others. The mHealth service segment is further categorized into prevention services, diagnostic services, monitoring services, treatment services, and wellness & healthcare system strengthening solutions. By application, the mHealth market classified into cardiovascular, diabetes, respiratory, neurology, and others. By stakeholder, the mHealth market is divided into mobile operators, device vendors, healthcare providers, and application & content players. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Boston Scientific Corporation, DexCom, Inc., FITBIT, INC. (Google), Koninklijke Philips N.V., Medtronic plc, Omada Health, Omron Corporation, SAMSUNG ELECTRONICS CO., LTD., Teladoc Health, Inc., and Welldoc, Inc. These major players have adopted product approval, agreement, acquisition, collaboration, merger, and product launch as key developmental strategies to improve the product portfolio of the mHealth market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the mhealth market analysis from 2022 to 2032 to identify the prevailing mhealth market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the mhealth market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global mhealth market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Average Selling Price Analysis / Price Point Analysis
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • SWOT Analysis

Key Market Segments

By Type

  • mHealth Devices
    • Device Type
    • Blood Glucose Monitors
    • Blood Pressure Monitors
    • Pulse Oximetry
    • Neurological Monitors
    • Cardiac Monitors
    • Apnea and Sleep Monitors
    • Wearable Fitness Sensor Devices and Heart Rate Meters
    • Others
  • mHealth Services
    • Service Type
    • Prevention Services
    • Diagnostic Services
    • Monitoring Services
    • Treatment Services
    • Wellness and Healthcare System Strengthening Solutions

By Application

  • Cardiovascular
  • Diabetes
  • Respiratory
  • Neurology
  • Others

By Stakeholders

  • Mobile operator
  • Device Vendors
  • Healthcare Providers
  • Application and Content Players

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Boston Scientific Corporation
    • DexCom, Inc.
    • Fitbit
    • Koninklijke Philips N.V.
    • Medtronic plc
    • Omada Health
    • Omron Corporation.
    • SAMSUNG ELECTRONICS CO., LTD.
    • Teladoc Health, Inc.
    • Welldoc, Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of cardiac diseases
      • 3.4.1.2. Increase in the incidence rate of diabetes
      • 3.4.1.3. Increase in demand for mHealth and wearable devices
    • 3.4.2. Restraints
      • 3.4.2.1. Concerns related to ensuring regulatory compliance
    • 3.4.3. Opportunities
      • 3.4.3.1. High growth potential in developing countries
      • 3.4.3.2. Rise in geriatric population
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MHEALTH MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. mHealth Devices
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. mHealth Devices mHealth Market by Device Type
  • 4.3. mHealth Services
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. mHealth Services mHealth Market by Service Type

CHAPTER 5: MHEALTH MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Cardiovascular
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Diabetes
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Respiratory
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Neurology
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Others
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: MHEALTH MARKET, BY STAKEHOLDERS

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Mobile operator
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Device Vendors
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Healthcare Providers
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Application and Content Players
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: MHEALTH MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by Stakeholders
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by Stakeholders
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by Stakeholders
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by Stakeholders
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by Stakeholders
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by Stakeholders
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by Stakeholders
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by Stakeholders
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by Stakeholders
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by Stakeholders
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by Stakeholders
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by Stakeholders
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by Stakeholders
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by Stakeholders
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by Stakeholders
      • 7.4.5.4. India
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by Stakeholders
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by Stakeholders
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Type
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by Stakeholders
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by Stakeholders
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by Stakeholders
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by Stakeholders
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by Stakeholders
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by Stakeholders

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Boston Scientific Corporation
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. DexCom, Inc.
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Fitbit
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Koninklijke Philips N.V.
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. Medtronic plc
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Omada Health
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Key strategic moves and developments
  • 9.7. Omron Corporation.
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.7. Key strategic moves and developments
  • 9.8. SAMSUNG ELECTRONICS CO., LTD.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. Welldoc, Inc
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Key strategic moves and developments
  • 9.10. Teladoc Health, Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments